Flu treatment using lipid target
Lipid mediator Leukotriene B4 is capable of reducing tissue damage from the flu
View news items and posts from some of our publications. For a complete publication list, please go here: https://meakinsmcgill.com/publications/
Lipid mediator Leukotriene B4 is capable of reducing tissue damage from the flu
Vulnerability of the host to Mycobacterium tuberculosis infection is due to a compromised gut microbiota
Dr. Dao Nguyen identifies promising cellular target that could make current and new antibiotics more effective
Publication by Maziar Divangahi and Nargis Khan in Science Immunology
Meet RIPK3: a biological weapon to combat the flu
Our natural variation in lung anatomy is associated with greater risk of COPD.
Cell publication on how BCG induces innate immune protection against M. Tuberculosis
Scientists discover peptide that could reduce the incidence of RSV-related asthma.
New study sheds light on the importance of newborn screening for Cystic Fibrosis patients
Potential vaccine redirects the immune response away from developing allergies